Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+27.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$39.1B
AUM Growth
+$39.1B
(+17%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-2.74%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
264
Reduced
307
Closed
110
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$2.23B |
| 2 |
Otis Worldwide
OTIS
|
$211M |
| 3 |
Burlington
BURL
|
$200M |
| 4 |
AbbVie
ABBV
|
$199M |
| 5 |
Wayfair
W
|
$190M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$1.66B |
| 2 |
Lockheed Martin
LMT
|
$327M |
| 3 |
Johnson & Johnson
JNJ
|
$253M |
| 4 |
Pfizer
PFE
|
$153M |
| 5 |
Target
TGT
|
$148M |
Sector Composition
| 1 | Technology | 21.53% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Financials | 11.32% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Moderna
MRNA
$9.41B
| $20.9M | 0.05% |
+325,000
| New | +$20.9M |
|
|
PRVL
377
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $20.8M | 0.05% |
1,396,169
+900,000
| +181% | +$13.4M |
|
378
Skyworks Solutions
SWKS
$10.8B
| $20.7M | 0.05% |
161,750
+58,900
| +57% | +$7.53M |
|
379
Teradyne
TER
$19.2B
| $20.5M | 0.05% |
+242,724
| New | +$20.5M |
|
380
Theravance Biopharma
TBPH
$697M
| $20.5M | 0.05% |
975,000
+200,000
| +26% | +$4.2M |
|
381
Tyson Foods
TSN
$20.1B
| $20.4M | 0.05% |
341,655
+5,100
| +2% | +$305K |
|
382
Diodes
DIOD
$2.47B
| $20.3M | 0.05% |
+400,000
| New | +$20.3M |
|
383
Akamai
AKAM
$11B
| $20.1M | 0.05% |
188,000
+3,200
| +2% | +$343K |
|
384
Ameren
AEE
$27B
| $20.1M | 0.05% |
+285,284
| New | +$20.1M |
|
385
Mid-America Apartment Communities
MAA
$16.7B
| $19.9M | 0.05% |
173,407
-40,143
| -19% | -$4.6M |
|
|
CVET
386
DELISTED
Covetrus, Inc. Common Stock
CVET
| $19.7M | 0.05% |
+1,100,000
| New | +$19.7M |
|
387
Lennar Class A
LEN
$34.4B
| $19.6M | 0.05% |
317,917
-5,200
| -2% | -$320K |
|
388
Conagra Brands
CAG
$8.99B
| $19.4M | 0.05% |
551,345
+10,800
| +2% | +$380K |
|
389
West Pharmaceutical
WST
$17.5B
| $19.4M | 0.05% |
+85,257
| New | +$19.4M |
|
390
Copart
CPRT
$46.9B
| $19.2M | 0.05% |
231,000
-4,200
| -2% | -$350K |
|
391
Kellanova
K
$27.4B
| $19.2M | 0.05% |
290,237
+4,600
| +2% | +$304K |
|
392
CDW
CDW
$21.3B
| $19.1M | 0.05% |
164,800
+800
| +0.5% | +$92.9K |
|
393
Allstate
ALL
$53.6B
| $19.1M | 0.05% |
197,019
-284,268
| -59% | -$27.6M |
|
394
Weyerhaeuser
WY
$18B
| $18.9M | 0.05% |
842,900
+659,612
| +360% | +$14.8M |
|
395
Oshkosh
OSK
$8.82B
| $18.8M | 0.05% |
261,927
-335,330
| -56% | -$24M |
|
396
Natera
NTRA
$23.2B
| $18.7M | 0.05% |
+375,000
| New | +$18.7M |
|
397
Corning
GLW
$58.7B
| $18.6M | 0.05% |
718,321
+22,000
| +3% | +$570K |
|
398
Amalgamated Financial
AMAL
$856M
| $18.6M | 0.05% |
1,469,294
+144,419
| +11% | +$1.83M |
|
399
Tesla
TSLA
$1.06T
| $18.4M | 0.05% |
+17,076
| New | +$18.4M |
|
400
Amcor
AMCR
$19.4B
| $18.4M | 0.05% |
1,805,390
-28,300
| -2% | -$289K |
|